IPO
Went public as NLS Pharmaceutics Ltd. Priced at US$4.15 a unit on Jan 28, 2021.
- Price
- US$4.15 a unit
- Units offered
- 4,819,277 units
- Offering size
- US$20 million
- Underwriters' option
- Up to 722,891 more units
- Listing
- NLSP on the Nasdaq Capital Market
- Underwriters
- Maxim Group LLC, Brookline Capital Markets · In the order on the cover
- Units delivered
- On or about Feb 2, 2021
Steps
| Step | When |
|---|
| Draft sent to the SEC in confidence | Dec 18, 2019 |
|---|
| Filed publicly | Feb 28, 2020 |
|---|
| Amended 5 times | Newest Jan 20, 2021 |
|---|
| Shares registered with an exchange | Jan 28, 2021 |
|---|
| Declared effective by the SEC | Jan 28, 2021 |
|---|
| Final prospectus, with the price | Feb 1, 2021 |
|---|
Filings
| Filing | Filed |
|---|
| 424B4 · Prospectus | Feb 1, 2021 |
|---|
| EFFECT · Notice that a registration is effective | Jan 28, 2021 |
|---|
| CERT · Exchange's certificate of listing | Jan 28, 2021 |
|---|
| CERT · Exchange's certificate of listing | Jan 28, 2021 |
|---|
| 8-A12B · Registration of shares for listing on an exchange | Jan 28, 2021 |
|---|
| CORRESP · Letter to the SEC | Jan 25, 2021 |
|---|
| CORRESP · Letter to the SEC | Jan 25, 2021 |
|---|
| F-1/A · Registration statement, amended | Jan 20, 2021 |
|---|
| CORRESP · Letter to the SEC | Nov 19, 2020 |
|---|
| F-1/A · Registration statement, amended | Nov 17, 2020 |
|---|
| UPLOAD · Letter from the SEC | Nov 17, 2020 |
|---|
| F-1/A · Registration statement, amended | Nov 13, 2020 |
|---|
| CORRESP · Letter to the SEC | Oct 19, 2020 |
|---|
| F-1/A · Registration statement, amended | Oct 19, 2020 |
|---|
| UPLOAD · Letter from the SEC | Sep 17, 2020 |
|---|
| CORRESP · Letter to the SEC | Aug 31, 2020 |
|---|
| F-1/A · Registration statement, amended | Aug 31, 2020 |
|---|
| UPLOAD · Letter from the SEC | Mar 3, 2020 |
|---|
| F-1 · Registration statement | Feb 28, 2020 |
|---|
| DRSLTR · Letter to the SEC with a draft | Feb 20, 2020 |
|---|
| DRS/A · Draft registration statement, amended | Feb 20, 2020 |
|---|
| UPLOAD · Letter from the SEC | Jan 15, 2020 |
|---|
| DRS · Draft registration statement | Dec 18, 2019 |
|---|
From the cover of the final prospectus (424B4) filed Feb 1, 2021